Accessibility Menu
Dyadic International Stock Quote

Dyadic International (NASDAQ: DYAI)

$0.92
(1.5%)
+0.01
Price as of November 25, 2025, 3:49 p.m. ET

KEY DATA POINTS

Current Price
$0.95
Daily Change
(1.5%) +$0.01
Day's Range
$0.91 - $1.00
Previous Close
$0.95
Open
$0.91
Beta
0.87
Volume
355,118
Average Volume
124,928
Market Cap
34.5M
Market Cap / Employee
$0.95M
52wk Range
$0.71 - $2.20
Revenue
-
Gross Margin
0.32%
Dividend Yield
N/A
EPS
-$0.24
CAPs Rating
-
Industry
Biotechnology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Dyadic International Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
DYAI-50.08%-83.24%-30.03%-85%
S&P+13%+86.41%+13.26%+480%

Dyadic International Company Info

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.

News & Analysis

Financial Health

General

Q3 2025YOY Change
Revenue$1.16M-40.5%
Gross Profit$0.14M-91.0%
Gross Margin12.07%-67.7%
Market Cap$42.70M39.3%
Market Cap / Employee$7.12M0.0%
Employees60.0%
Net Income-$1.98M-871.2%
EBITDA-$1.91M-872.7%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q3 2025YOY Change
Net Cash$7.16M20.8%
Accounts Receivable$0.92M159.7%
Inventory00.0%

Liabilities

Q3 2025YOY Change
Long Term Debt$5.01M-5.7%
Short Term Debt$0.05M-8.5%

Ratios

Q3 2025YOY Change
Return On Assets-65.38%-2.3%
Return On Invested Capital-76.63%-10.9%

Cash Flow

Q3 2025YOY Change
Free Cash Flow-$1.85M-821.3%
Operating Free Cash Flow-$1.85M-821.3%

Valuation

MetricQ4 2024Q1 2025Q2 2025Q3 2025YoY Change
Price to Book15.1816.3032.26-67.12-844.28%
Price to Sales14.9411.357.2112.1833.59%
Price to Tangible Book Value15.1816.3132.25-67.13-844.37%
Enterprise Value to EBITDA-31.56-19.08-16.52-18.57-86.02%
Return on Equity-139.2%-214.3%-422.6%-244.2%113.38%
Total Debt$5.07M$5.07M$5.06M$5.06M-5.73%

No results found

No podcast episodes available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.